FDA Adverse Event Malfunction Summary report: N

LENSX LASER SYSTEM

MDR report key: 15075874 · Received July 21, 2022

Report

Report Number
2028159-2022-00997
Event Type
Malfunction
Date Received
July 21, 2022
Date of Event
June 16, 2022
Report Date
October 18, 2022
Manufacturer
ALCON LENSX, INC.
Product Code
OOE
UDI-DI
00380659981623
PMA / PMN Number
K163551
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION, INCLUDING ROOT CAUSE ANALYSIS, IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. ALCON LENSX (SITE #(B)(4)) IS NO LONGER OPERATIONAL. LENSX MANUFACTURED PRODUCTS ARE MAINTAINED AND INVESTIGATED BY THE ALCON RESEARCH, LTD. IRVINE TECHNOLOGY CENTER SITE #(B)(4)). THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Additional Manufacturer Narrative · 0

ALCON LENSX (SITE #3008772169) IS NO LONGER OPERATIONAL. LENSX MANUFACTURED PRODUCTS ARE MAINTAINED AND INVESTIGATED BY THE ALCON RESEARCH, LTD. IRVINE TECHNOLOGY CENTER SITE #(B)(4)). THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Description of Event or Problem · 0

A HEALTHCARE PROFESSIONAL REPORTED A PATIENT WITH FLAP THICKNESS VARYING FROM 200 MICRON TO 180 MICRONS AT HORIZONTAL SECTION. THERE ARE TWO RELATED REPORTS FOR THIS PATIENT. THIS REPORT ADDRESSES THE PATIENT'S LEFT EYE AND ANOTHER MANUFACTURER REPORT WILL BE FILED FOR THE FELLOW EYE.

Description of Event or Problem · 0

REASSESSMENT OF THE INITIAL INFORMATION, NO ADDITIONAL INFORMATION RECEIVED ON THE FLAP THICKNESS AND NO RESULTS OF POST ONE MONTH OPTICAL COHERENCE TOMOGRAPHY MEASUREMENTS. HENCE, NOT QUALIFIED FOR THE REPORTABLE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1653912 LENSX LASER SYSTEM OPHTHALMIC FEMTOSECOND LASER OOE ALCON LENSX, INC. 550 NA 00380659981623

Patients

Seq Age Sex Outcome Treatment
1 Male